These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 813934)

  • 21. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.
    Ralph P; Prichard J; Cohn M
    J Immunol; 1975 Feb; 114(2 pt 2):898-905. PubMed ID: 1089721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of a non-specific cytotoxic factor by splenic cells immunized against allogeneic tumour cells.
    Hottier D; Donner M; Burg C
    Rev Eur Etud Clin Biol; 1971 Mar; 16(3):240-3. PubMed ID: 5104840
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective suppression of murine antibody-dependent cell-mediated cytotoxicity by azathioprine.
    Purves EC; Berenbaum MC
    Transplantation; 1975 Mar; 19(3):274-6. PubMed ID: 1094641
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of erythromycin on immunity in immunodeficiency].
    Sakaeva DD; Lazareva DN
    Eksp Klin Farmakol; 1999; 62(1):50-2. PubMed ID: 10198768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
    Orsini F; Eppolito C; Ehrke MJ; Mihich E
    Cancer Treat Rep; 1980; 64(2-3):211-8. PubMed ID: 6967756
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
    Nanishi F; Nomoto K; Taniguchi K; Kubo C
    Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The immunotropic properties of rifampicin and their correction].
    Sakaeva DD; Lazareva DN
    Eksp Klin Farmakol; 1998; 61(2):45-7. PubMed ID: 9621174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse effector functions involved in the antibody-dependent cellular cytotoxicity to xenogeneic erythrocytes.
    Cohen SA; Ehrke MJ; Mihich E
    J Immunol; 1975 Oct; 115(4):1007-12. PubMed ID: 1100718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of carrageenan on the induction of cell-mediated cytotoxic responses in vivo.
    Sakemi T; Kuroiwa A; Nomoto K
    Immunology; 1980 Oct; 41(2):297-302. PubMed ID: 6969217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splenic mediated erythrocyte cytotoxicity in malaria.
    Coleman RM; Rencricca NJ; Stout JP; Brissette WH; Smith DM
    Immunology; 1975 Jul; 29(1):49-54. PubMed ID: 1095474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid.
    Ponzio NM; Speirs RS
    Immunology; 1975 Feb; 28(2):243-51. PubMed ID: 1079015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the cytotoxic response against allogeneic tumor cells in culture by adriamycin.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1980 Aug; 40(8 Pt 1):2748-55. PubMed ID: 6248213
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoregulatory d-globulin: failure to inhibit antibody response when administered after antigen exposure.
    Glasgow AH; Menzoian JO; Cooperband SR; Nimberg RB; Schmid K; Mannick JA
    J Immunol; 1973 Jul; 111(1):272-4. PubMed ID: 4123372
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation of "sneaking through" of tumor cells with specific immunological impairment of the host.
    Mengersen R; Schick R; Kölsch E
    Eur J Immunol; 1975 Aug; 5(8):532-7. PubMed ID: 61875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice.
    Greenberg AH; Playfair JH
    Clin Exp Immunol; 1974 Jan; 16(1):99-109. PubMed ID: 4143189
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunosuppression of experimental autoimmune myasthenia gravis by hydrocortisone and azathioprine.
    Abramsky O; Tarrab-Hazdai R; Aharonov A; Fuchs S
    J Immunol; 1976 Jul; 117(1):225-8. PubMed ID: 932425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro.
    Song CW; Levitt SH
    Radiology; 1974 Apr; 111(1):211-2. PubMed ID: 4205812
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody-dependent cytolysis of chicken erythrocytes by an in vitro-established line of mouse peritoneal macrophages.
    Walker WS; Demus A
    J Immunol; 1975 Feb; 114(2 pt 2):765-9. PubMed ID: 1167563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.